Itron Reports Strong 2025 Profitability but Issues Lower-Than-Expected 2026 EPS Guidance
summarizeSummary
Itron, Inc. announced strong fourth quarter and full-year 2025 financial results, with significant increases in net income, EPS, and free cash flow, driven by growth in its Outcomes segment and strategic acquisitions. However, the company's full-year 2026 non-GAAP diluted EPS guidance is notably lower than 2025 actuals.
check_boxKey Events
-
Strong Q4 and Full-Year 2025 Profitability
Itron reported a 75% increase in Q4 2025 GAAP diluted EPS to $2.21 and a 23% increase for the full year to $6.50. Non-GAAP diluted EPS also saw substantial gains, rising 82% in Q4 to $2.46 and 27% for the full year to $7.13. Adjusted EBITDA and free cash flow also showed significant year-over-year improvements, driven by a 560 basis point increase in Q4 gross margin and 23% growth in Outcomes revenue.
-
Strategic Acquisitions Completed
The company announced the acquisition of Urbint, which contributed $3 million in Q4 2025 revenue, and completed the $525 million acquisition of Locusview in January 2026, funded by cash on hand. These acquisitions are intended to enhance AI-enhanced software solutions and recurring revenue.
-
Lower Full-Year 2026 EPS Guidance
Itron provided full-year 2026 non-GAAP diluted EPS guidance of $5.75 to $6.25, which is significantly lower than the $7.13 achieved in full-year 2025. The full-year 2026 revenue outlook is between $2.35 billion and $2.45 billion, relatively flat compared to 2025 actuals.
auto_awesomeAnalysis
Itron, Inc. delivered robust profitability in Q4 and full-year 2025, with significant increases in GAAP and non-GAAP net income, EPS, Adjusted EBITDA, and free cash flow, despite a slight revenue decline. This performance was bolstered by strong growth in its Outcomes segment and strategic acquisitions like Urbint and Locusview, the latter a substantial $525 million deal. However, the company's full-year 2026 non-GAAP diluted EPS guidance of $5.75 to $6.25 is notably lower than the $7.13 achieved in 2025. This downward revision in future earnings expectations is a significant negative signal for investors, especially as the stock is currently trading near its 52-week low, suggesting potential pressure on the share price.